BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng WL, Feng PH, Lee KY, Chen KY, Sun WL, Van Hiep N, Luo CS, Wu SM. The Role of EREG/EGFR Pathway in Tumor Progression. Int J Mol Sci 2021;22:12828. [PMID: 34884633 DOI: 10.3390/ijms222312828] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiao Z, Li M, Zhang X, Rong X, Xu H. TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway. Oncol Rep 2023;49:84. [PMID: 36896765 DOI: 10.3892/or.2023.8521] [Reference Citation Analysis]
2 Wiesehöfer M, Raczinski BBG, Wiesehöfer C, Dankert JT, Czyrnik ED, Spahn M, Kruithof-de Julio M, Wennemuth G. Epiregulin expression and secretion is increased in castration-resistant prostate cancer. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1107021] [Reference Citation Analysis]
3 Jehl A, Conrad O, Burgy M, Foppolo S, Vauchelles R, Ronzani C, Etienne-Selloum N, Chenard MP, Danic A, Dourlhes T, Thibault C, Schultz P, Dontenwill M, Martin S. Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction. Cells 2023;12. [PMID: 36899869 DOI: 10.3390/cells12050733] [Reference Citation Analysis]
4 Yoshinouchi S, Karouji K, Tominari T, Sugasaki M, Matsumoto C, Miyaura C, Hirata M, Itoh Y, Inada M. Prostate cancer expressing membrane-bound TGF-α induces bone formation mediated by the autocrine effect of prostaglandin E(2) in osteoblasts. Biochem Biophys Res Commun 2023;644:40-8. [PMID: 36623397 DOI: 10.1016/j.bbrc.2022.11.050] [Reference Citation Analysis]
5 Sidorov M, Dighe P, Woo RWL, Rodriguez-Brotons A, Chen M, Ice RJ, Vaquero E, Jian D, Desprez PY, Nosrati M, Galvez L, Leng L, Dickinson L, Kashani-Sabet M, McAllister SD, Soroceanu L. Dual Targeting of EGFR and MTOR Pathways Inhibits Glioblastoma Growth by Modulating the Tumor Microenvironment. Cells 2023;12. [PMID: 36831214 DOI: 10.3390/cells12040547] [Reference Citation Analysis]
6 Nie Z, Zhang K, Li Z, Bing X, Jin S, Li M. Human papillomavirus 16 E6 promotes angiogenesis of lung cancer via SNHG1. Cell Biochem Biophys 2023. [PMID: 36690880 DOI: 10.1007/s12013-022-01121-0] [Reference Citation Analysis]
7 Hou B, Chen T, Zhang H, Li J, Wang P, Shang G. The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy. Front Immunol 2023;14:1123244. [PMID: 36733484 DOI: 10.3389/fimmu.2023.1123244] [Reference Citation Analysis]
8 Liu C, Li Y. Hsa_circ_0000078 Regulates miR-205-5p/EREG Pathway to Inhibit Cervical Cancer Progression. Mol Biotechnol 2023. [PMID: 36645579 DOI: 10.1007/s12033-023-00658-6] [Reference Citation Analysis]
9 Tabbal M, Hachim MY, Jan RK, Adrian TE. Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women. Front Genet 2022;13:1039037. [PMID: 36685821 DOI: 10.3389/fgene.2022.1039037] [Reference Citation Analysis]
10 Liu Y, He E, Zhang Y, Liu Y, Wang Y, Chen S, Wu X, Zeng Y, Leng P. WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review. Gland Surg 2022;11:1984-2002. [PMID: 36654949 DOI: 10.21037/gs-22-716] [Reference Citation Analysis]
11 Van Hiep N, Sun WL, Feng PH, Lin CW, Chen KY, Luo CS, Dung LN, Van Quyet H, Wu SM, Lee KY. Heparin binding epidermal growth factor-like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma. Front Oncol 2022;12:963896. [PMID: 36439487 DOI: 10.3389/fonc.2022.963896] [Reference Citation Analysis]
12 Li J, Fu Y, Zhang K, Li Y. Integration of Bulk and Single-Cell RNA-Seq Data to Construct a Prognostic Model of Membrane Tension-Related Genes for Colon Cancer. Vaccines (Basel) 2022;10:1562. [PMID: 36146640 DOI: 10.3390/vaccines10091562] [Reference Citation Analysis]
13 Matuszyk J. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. Mol Med 2022;28:89. [PMID: 35922756 DOI: 10.1186/s10020-022-00516-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Kim YS, Sun S, Ahn J, Kim Y, Yoon JS, Won HS. Analysis of Genomic Alterations Associated with Recurrence in Early Stage HER2-Positive Breast Cancer. Cancers (Basel) 2022;14. [PMID: 35954313 DOI: 10.3390/cancers14153650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wang K, Chen YF, Yang YSH, Huang HM, Lee SY, Shih YJ, Li ZL, Whang-Peng J, Lin HY, Davis PJ. The power of heteronemin in cancers. J Biomed Sci 2022;29:41. [PMID: 35705962 DOI: 10.1186/s12929-022-00816-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang H, Liu J, Gao J, Yan W, Rehan VK. Perinatal Exposure to Nicotine Alters Sperm RNA Profiles in Rats. Front Endocrinol (Lausanne) 2022;13:893863. [PMID: 35600600 DOI: 10.3389/fendo.2022.893863] [Reference Citation Analysis]
17 Zhang L, Nan F, Yang L, Dong Y, Tian Y. Differentially expressed EREG and SPP1 are independent prognostic markers in cervical squamous cell carcinoma. J of Obstet and Gynaecol. [DOI: 10.1111/jog.15265] [Reference Citation Analysis]
18 Ascenção K, Szabo C. Emerging roles of cystathionine β-synthase in various forms of cancer. Redox Biology 2022. [DOI: 10.1016/j.redox.2022.102331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
19 Dayanc B, Eris S, Senturk S. Challenges in First-Line Osimertinib Therapy in EGFR-Mutant Non-small Cell Lung Cancer: Acquired Resistance Is the Issue. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_54] [Reference Citation Analysis]